What may be prescribed to manage insulin resistance after discharge?

Metformin is widely prescribed to manage insulin resistance due to its effectiveness in improving insulin sensitivity and lowering blood glucose levels. It works primarily by decreasing hepatic glucose production and enhancing peripheral glucose uptake. This makes it particularly useful for patients who are at risk of developing type 2 diabetes or who have metabolic syndrome, both of which can be associated with insulin resistance.

In post-discharge care, patients may face challenges in managing their blood sugar levels, particularly if they have experienced severe illness or have a history of glucose dysregulation. Metformin can be an appropriate choice because it is generally well-tolerated, does not cause weight gain (and may even contribute to weight loss), and can be taken orally, making it easier for patients to adhere to their medication regimen.

Other options, while they have their own roles in glucose management, are not as commonly prescribed specifically for managing insulin resistance. Insulin therapy is typically reserved for more acute situations or when other medications are insufficient. Glucose supplementation would be counterproductive in the context of insulin resistance, as it would further elevate blood sugar levels. Acarbose, while useful for some patients by delaying carbohydrate absorption, is less commonly the primary choice compared to metformin for directly addressing insulin resistance.